Truist Financial Corp Bio Rad Laboratories, Inc. Transaction History

Truist Financial Corp

  • $62.7 Billion
  • Q4 2024

A detailed history of Truist Financial Corp transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Truist Financial Corp holds 9,186 shares of BIO stock, worth $3.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,186
Previous 9,114 0.79%
Holding current value
$3.14 Million
Previous $3.05 Million 1.05%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025
BUY
$313.15 - $374.28 $22,546 - $26,948
72 Added 0.79%
9,186 $3.02 Million
Q3 2024

Nov 13, 2024
BUY
$263.97 - $344.64 $48,306 - $63,069
183 Added 2.05%
9,114 $3.05 Million
Q2 2024

Aug 20, 2024
SELL
$268.26 - $339.48 $467,308 - $591,374
-1,742 Reduced 16.32%
8,931 $2.44 Million
Q1 2024

May 10, 2024
SELL
$304.11 - $351.99 $292,553 - $338,614
-962 Reduced 8.27%
10,673 $3.69 Million
Q4 2023

Feb 02, 2024
SELL
$269.37 - $365.04 $857,674 - $1.16 Million
-3,184 Reduced 21.49%
11,635 $3.76 Million
Q3 2023

Nov 14, 2023
BUY
$350.25 - $422.63 $10,857 - $13,101
31 Added 0.21%
14,819 $5.31 Million
Q2 2023

Aug 01, 2023
BUY
$359.49 - $486.4 $735,516 - $995,174
2,046 Added 16.06%
14,788 $5.61 Million
Q1 2023

May 05, 2023
BUY
$418.69 - $503.0 $129,375 - $155,427
309 Added 2.49%
12,742 $6.1 Million
Q4 2022

Feb 17, 2023
BUY
$351.71 - $456.01 $894,398 - $1.16 Million
2,543 Added 25.71%
12,433 $5.23 Million
Q3 2022

Oct 26, 2022
BUY
$412.59 - $563.26 $212,896 - $290,642
516 Added 5.5%
9,890 $4.13 Million
Q2 2022

Jul 22, 2022
SELL
$463.67 - $597.16 $513,282 - $661,056
-1,107 Reduced 10.56%
9,374 $4.64 Million
Q1 2022

Apr 22, 2022
SELL
$524.57 - $735.42 $689,809 - $967,077
-1,315 Reduced 11.15%
10,481 $5.9 Million
Q4 2021

Feb 14, 2022
SELL
$708.84 - $794.68 $404,038 - $452,967
-570 Reduced 4.61%
11,796 $8.91 Million
Q3 2021

Nov 05, 2021
BUY
$657.71 - $825.77 $195,997 - $246,079
298 Added 2.47%
12,366 $9.22 Million
Q2 2021

Aug 16, 2021
SELL
$576.64 - $649.04 $56,510 - $63,605
-98 Reduced 0.81%
12,068 $7.78 Million
Q1 2021

May 17, 2021
BUY
$547.01 - $662.35 $542,633 - $657,051
992 Added 8.88%
12,166 $6.95 Million
Q4 2020

Nov 19, 2021
SELL
$510.68 - $643.45 $1.2 Million - $1.51 Million
-2,341 Reduced 17.32%
11,174 $6.51 Million
Q4 2020

Feb 18, 2021
BUY
$510.68 - $643.45 $735,889 - $927,211
1,441 Added 11.93%
13,515 $7.88 Million
Q3 2020

Nov 13, 2020
SELL
$454.43 - $535.6 $545,316 - $642,720
-1,200 Reduced 9.04%
12,074 $6.22 Million
Q2 2020

Aug 14, 2020
BUY
$334.87 - $493.06 $252,826 - $372,260
755 Added 6.03%
13,274 $5.99 Million
Q1 2020

May 15, 2020
BUY
$320.01 - $409.07 $33,921 - $43,361
106 Added 0.85%
12,519 $4.39 Million
Q4 2019

Feb 14, 2020
BUY
$319.73 - $374.2 $3.5 Million - $4.1 Million
10,953 Added 750.21%
12,413 $4.59 Million
Q3 2019

Oct 31, 2019
SELL
$304.55 - $345.24 $13,095 - $14,845
-43 Reduced 2.86%
1,460 $486,000
Q2 2019

Jul 24, 2019
BUY
$286.93 - $312.59 $13,485 - $14,691
47 Added 3.23%
1,503 $469,000
Q1 2019

Apr 23, 2019
BUY
$224.3 - $317.41 $32,299 - $45,707
144 Added 10.98%
1,456 $445,000
Q4 2018

Jan 22, 2019
BUY
$220.1 - $309.0 $38,957 - $54,693
177 Added 15.59%
1,312 $304,000
Q3 2018

Oct 17, 2018
SELL
$289.28 - $326.15 $82,444 - $92,952
-285 Reduced 20.07%
1,135 $355,000
Q2 2018

Jul 26, 2018
BUY
$244.1 - $303.88 $346,622 - $431,509
1,420 New
1,420 $410,000

Others Institutions Holding BIO

# of Institutions
457
Shares Held
18.7M
Call Options Held
19.5K
Put Options Held
13.9K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.43B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Truist Financial Corp Portfolio

Follow Truist Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email